Purchase Order 75N95A19P00160

This federal contract award to Biomatters Incorporated, a bioinformatics software company, is for the upgrade of the Geneious software suite. The $6,385 firm-fixed-price purchase order was awarded by the Department of the Interior Fish and Wildlife Service Region 9 Headquarters and has a completion date of January 20, 2018. The contract does not include a set-aside designation. Biomatters Incorporated is the prime contractor and is not associated with any major subcontractors for this award. The...

This $48,336.59 firm fixed price delivery order was awarded against the Chief Information Officer Commodities and Solutions government-wide acquisition contract to New TECH Solutions, Inc. of Fremont, California for a GENEIOUS SEQUENCE SUBSCRIPTION. Set aside for total small businesses, this order from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases is for software and related services to support the agency's...

<p>The National Cancer Institute awarded a purchase order to Rapid Novor Inc. for sequencing services valued at $21,000 on March 30, 2020. Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada, with an ultimate completion date of April 17, 2021.</p>

<p>This is a Delivery Order awarded by the National Cancer Institute (NCI) to Inspirata Canada Inc. (doing business as A I M) for $1,999,910.00 to provide SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER) ELECTRONIC DATA CAPTURE SOFTWARE SUPPORT AND INSTALLATION services. The order has a period of performance from September 26, 2016 to September 25, 2017 and was awarded on a Firm Fixed Price basis with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Gene42 Inc. for $120,850 on August 18, 2017, to provide software development and support for the PhenoTips server deployed in the UDP Program at NIH/NHGRI. Work is performed in Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of August 17, 2020.</p>

The National Cancer Institute issued a $72,109.31 delivery order to New TECH Solutions, Inc. on July 11, 2026, under the Chief Information Officer Commodities and Solutions (CIO-CS) GWAC for Partek Genomics Suite and Partek Flow software. CIO-CS is a government-wide acquisition contract for IT commodities and solutions. Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of July 10, 2027. New TECH Solutions is a Subcontinent Asian American-owned...

This firm-fixed-price purchase order for $302,039.20 was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to BostonGene Corporation. The contract is for targeted deep sequencing and bioinformatics analysis of 162 human plasma samples to support a clinical trial investigating the safety and efficacy of the Copanlisib/Rituximab combination treatment for previously untreated follicular lymphoma patients. The objective is to obtain plasma...

<p>The National Cancer Institute issued a delivery order to Blue TECH Inc. on June 25, 2018, under the Chief Information Officer Commodities and Solutions (CIO-CS) GWAC for a one-year academic license of Genespring GX software, with a ceiling value of $60,867.29.</p> <p>Blue TECH Inc. is a woman-owned small business and HUBZone-certified firm. The order was issued under a HUBZone set-aside. Place of performance is La Jolla, CA. The ultimate completion date is August 16, 2019.</p>

The National Cancer Institute issued a delivery order to New TECH Solutions, Inc. on December 7, 2015, for maintenance of GeneCode's Sequencher software, with a ceiling value of $5,785.78, under the Chief Information Officer Commodities and Solutions (CIO-CS) GWAC. CIO-CS is a GSA-administered governmentwide acquisition contract for IT commodities and solutions supporting federal agencies. Place of performance is Fremont, CA 94538. The order is firm fixed price with an ultimate completion date...

The United States Patent and Trademark Office (USPTO) awarded a Firm Fixed Price purchase order to Biocceleration Inc., a for-profit organization, to renew an expiring contract for operations and maintenance (O&amp;M) services. The contract, valued at $6,263,840.00, has an ultimate completion date of April 30, 2025. The contract is not set aside and is for the continuation of Biocceleration's software and license maintenance services, installation, training, and premier operation support for the...